紧急-话题@MedSci

#紧急#

240篇内容 | 1970人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1523337, encodeId=af6e152333e33, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, objectType=article, longId=209484, objectId=493e20948420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=493e20948420, replyNumber=0, likeNumber=51, createdTime=2021-04-05, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=493e20948420, moduleTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=493e20948420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523336, encodeId=593f1523336a7, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, objectType=article, longId=209421, objectId=764820942176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=764820942176, replyNumber=0, likeNumber=67, createdTime=2021-04-05, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=764820942176, moduleTitle=国际！中科院研发的这款重组新冠疫苗获批紧急使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=764820942176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523335, encodeId=19f815233355d, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=又一COVID-19潜在药物有望上市，GSK/Vir提交单抗VIR-7831紧急使用授权申请, objectType=article, longId=209234, objectId=7d6920923452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d6920923452, replyNumber=0, likeNumber=58, createdTime=2021-04-01, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d6920923452, moduleTitle=又一COVID-19潜在药物有望上市，GSK/Vir提交单抗VIR-7831紧急使用授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d6920923452)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523334, encodeId=d7b31523334d3, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=葛兰素史克（GSK）寻求COVID-19单克隆抗体VIR-7831的紧急授权, objectType=article, longId=209106, objectId=7c5620910665, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c5620910665, replyNumber=0, likeNumber=75, createdTime=2021-03-29, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c5620910665, moduleTitle=葛兰素史克（GSK）寻求COVID-19单克隆抗体VIR-7831的紧急授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c5620910665)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523333, encodeId=21cd15233337b, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=FDA批准第三款新冠疫苗紧急使用授权, objectType=article, longId=208098, objectId=ded120809874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ded120809874, replyNumber=0, likeNumber=70, createdTime=2021-03-09, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ded120809874, moduleTitle=FDA批准第三款新冠疫苗紧急使用授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ded120809874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523332, encodeId=3eca1523332e6, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=墨西哥宣布批准紧急使用两款中国新冠疫苗，中国新冠疫苗惠及全球数十个国家和地区, objectType=article, longId=207066, objectId=7d9420e0660b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d9420e0660b, replyNumber=0, likeNumber=56, createdTime=2021-02-13, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d9420e0660b, moduleTitle=墨西哥宣布批准紧急使用两款中国新冠疫苗，中国新冠疫苗惠及全球数十个国家和地区, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d9420e0660b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523331, encodeId=ce9f1523331d8, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=Circulation：WHF、ACC、AHA、ESC四大国际心血管学术组织发布联合声明，呼吁采取紧急行动减少空气污染及暴露以改善心血管健康, objectType=article, longId=206592, objectId=107d206592a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=107d206592a0, replyNumber=0, likeNumber=66, createdTime=2021-02-03, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=107d206592a0, moduleTitle=Circulation：WHF、ACC、AHA、ESC四大国际心血管学术组织发布联合声明，呼吁采取紧急行动减少空气污染及暴露以改善心血管健康, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=107d206592a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523330, encodeId=a6b41523330a7, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=强生新冠疫苗III期研究成功，单次接种预防中重度COVID-19有效率66%！即将向FDA提交紧急使用授权申请, objectType=article, longId=206583, objectId=ab6920658334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6920658334, replyNumber=0, likeNumber=58, createdTime=2021-02-03, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6920658334, moduleTitle=强生新冠疫苗III期研究成功，单次接种预防中重度COVID-19有效率66%！即将向FDA提交紧急使用授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab6920658334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523329, encodeId=850415233294d, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=WHF、ACC、AHA、ESC四大国际心血管学术组织发布联合声明，呼吁采取紧急行动减少空气污染及暴露以改善心血管健康, objectType=article, longId=206538, objectId=aaeb20653899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaeb20653899, replyNumber=0, likeNumber=81, createdTime=2021-02-02, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaeb20653899, moduleTitle=WHF、ACC、AHA、ESC四大国际心血管学术组织发布联合声明，呼吁采取紧急行动减少空气污染及暴露以改善心血管健康, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaeb20653899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523328, encodeId=a6441523328f4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=目前哪些国家订购了中国的新冠疫苗？全新摩洛哥批准紧急使用中国新冠疫苗, objectType=article, longId=206204, objectId=d85620620498, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85620620498, replyNumber=0, likeNumber=81, createdTime=2021-01-26, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85620620498, moduleTitle=目前哪些国家订购了中国的新冠疫苗？全新摩洛哥批准紧急使用中国新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85620620498)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523327, encodeId=a7ca152332ed6, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=世卫组织发布新冠疫苗紧急使用认证, objectType=article, longId=205215, objectId=b1a4205215a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1a4205215a8, replyNumber=0, likeNumber=73, createdTime=2021-01-03, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1a4205215a8, moduleTitle=世卫组织发布新冠疫苗紧急使用认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1a4205215a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523326, encodeId=8b9c15233268e, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=从腹泻到死亡仅12小时！心律失常的紧急处理，我们总结了这7个要点, objectType=article, longId=204797, objectId=566e204e972d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=566e204e972d, replyNumber=0, likeNumber=43, createdTime=2020-12-24, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=566e204e972d, moduleTitle=从腹泻到死亡仅12小时！心律失常的紧急处理，我们总结了这7个要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=566e204e972d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523325, encodeId=248b1523325ad, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=美国抗疫重大里程碑：FDA正式批准辉瑞疫苗紧急使用授权申请, objectType=article, longId=204436, objectId=572d204436b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=572d204436b1, replyNumber=0, likeNumber=83, createdTime=2020-12-14, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=572d204436b1, moduleTitle=美国抗疫重大里程碑：FDA正式批准辉瑞疫苗紧急使用授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=572d204436b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523324, encodeId=aa0f15233242d, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权, objectType=article, longId=204415, objectId=8ae32044156a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae32044156a, replyNumber=0, likeNumber=94, createdTime=2020-12-13, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae32044156a, moduleTitle=NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae32044156a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523323, encodeId=f18515233239c, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=美FDA发布德美研发的新冠疫苗分析报告：符合紧急使用授权标准, objectType=article, longId=204355, objectId=988d2043557e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=988d2043557e, replyNumber=0, likeNumber=76, createdTime=2020-12-11, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=988d2043557e, moduleTitle=美FDA发布德美研发的新冠疫苗分析报告：符合紧急使用授权标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=988d2043557e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523322, encodeId=288c1523322ad, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=成都理工大学发布加强疫情防控紧急通知：师生员工原则上不得离校外出, objectType=article, longId=204341, objectId=c26a20434125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c26a20434125, replyNumber=0, likeNumber=64, createdTime=2020-12-10, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c26a20434125, moduleTitle=成都理工大学发布加强疫情防控紧急通知：师生员工原则上不得离校外出, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c26a20434125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523321, encodeId=7cf0152332116, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=再生元“抗体鸡尾酒疗法”获批紧急使用授权，将免费供给30万名患者, objectType=article, longId=204195, objectId=9a83204195f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a83204195f5, replyNumber=0, likeNumber=54, createdTime=2020-12-07, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a83204195f5, moduleTitle=再生元“抗体鸡尾酒疗法”获批紧急使用授权，将免费供给30万名患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a83204195f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523320, encodeId=ccb3152332044, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=辉瑞mRNA新冠疫苗在英国获批紧急使用, objectType=article, longId=204105, objectId=745c20410569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=745c20410569, replyNumber=0, likeNumber=77, createdTime=2020-12-05, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=745c20410569, moduleTitle=辉瑞mRNA新冠疫苗在英国获批紧急使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=745c20410569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523319, encodeId=ce92152331917, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=美国紧急召回恐遭大肠杆菌污染生菜，或与13个州大肠杆菌疫情爆发有关, objectType=article, longId=203334, objectId=02c4203334c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02c4203334c5, replyNumber=0, likeNumber=36, createdTime=2020-11-15, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02c4203334c5, moduleTitle=美国紧急召回恐遭大肠杆菌污染生菜，或与13个州大肠杆菌疫情爆发有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02c4203334c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1523318, encodeId=f37e1523318d5, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, objectTitle=礼来的中和抗体bamlanivimab获得FDA紧急使用授权，用于治疗轻中度新冠COVID-19感染患者, objectType=article, longId=203247, objectId=649f20324ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649f20324ef1, replyNumber=0, likeNumber=70, createdTime=2020-11-12, rootId=0, userName=guguangxiang, userId=b88211514540, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649f20324ef1, moduleTitle=礼来的中和抗体bamlanivimab获得FDA紧急使用授权，用于治疗轻中度新冠COVID-19感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649f20324ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

紧急

2020-05-29

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

国际！中科院研发的这款重组新冠疫苗获批紧急使用

2021-04-05

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

国际！中科院研发的这款重组新冠疫苗获批紧急使用

2021-04-05

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

又一COVID-19潜在药物有望上市，GSK/Vir提交单抗VIR-7831紧急使用授权申请

2021-04-01

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

葛兰素史克（GSK）寻求COVID-19单克隆抗体VIR-7831的紧急授权

2021-03-29

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

FDA批准第三款新冠疫苗紧急使用授权

2021-03-09

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

墨西哥宣布批准紧急使用两款中国新冠疫苗，中国新冠疫苗惠及全球数十个国家和地区

2021-02-13

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

Circulation：WHF、ACC、AHA、ESC四大国际心血管学术组织发布联合声明，呼吁采取紧急行动减少空气污染及暴露以改善心血管健康

2021-02-03

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

强生新冠疫苗III期研究成功，单次接种预防中重度COVID-19有效率66%！即将向FDA提交紧急使用授权申请

2021-02-03

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

WHF、ACC、AHA、ESC四大国际心血管学术组织发布联合声明，呼吁采取紧急行动减少空气污染及暴露以改善心血管健康

2021-02-02

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

目前哪些国家订购了中国的新冠疫苗？全新摩洛哥批准紧急使用中国新冠疫苗

2021-01-26

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

世卫组织发布新冠疫苗紧急使用认证

2021-01-03

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

从腹泻到死亡仅12小时！心律失常的紧急处理，我们总结了这7个要点

2020-12-24

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

美国抗疫重大里程碑：FDA正式批准辉瑞疫苗紧急使用授权申请

2020-12-14

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

NEJM：辉瑞/BioNTech新冠mRNA疫苗有效率为95%！FDA将紧急应用授权

2020-12-13

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

美FDA发布德美研发的新冠疫苗分析报告：符合紧急使用授权标准

2020-12-11

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

成都理工大学发布加强疫情防控紧急通知：师生员工原则上不得离校外出

2020-12-10

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

再生元“抗体鸡尾酒疗法”获批紧急使用授权，将免费供给30万名患者

2020-12-07

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

辉瑞mRNA新冠疫苗在英国获批紧急使用

2020-12-05

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

美国紧急召回恐遭大肠杆菌污染生菜，或与13个州大肠杆菌疫情爆发有关

2020-11-15

guguangxiang (审核中...)

前往app查看评论内容

#紧急#

礼来的中和抗体bamlanivimab获得FDA紧急使用授权，用于治疗轻中度新冠COVID-19感染患者

2020-11-12

科室
- - 订阅+
  - 更多科室
工具
服务